Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-06

Clinical Trial Update: Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing vortioxetine to other antidepressants with pregabalin augmentation for Burning Mouth Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vortioxetine (vortioxetine)
  • other antidepressants with pregabalin augmentation

Snippet

Sponsor: Federico II University | Conditions: Burning Mouth Syndrome | Phase 3 | Status: UNKNOWN